Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)
China
· Delayed Price · Currency is CNY 12.09
+0.19 (1.60%)
Apr 30, 2026, 2:55 PM CST
SHA:603520 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 2,446 | 2,013 | 1,996 | 1,868 | 1,873 | Upgrade
|
| Other Revenue | - | 337.09 | 200.4 | 263.61 | 126.7 | Upgrade
|
| Revenue | 2,446 | 2,350 | 2,196 | 2,131 | 2,000 | Upgrade
|
| Revenue Growth (YoY) | 4.06% | 7.02% | 3.04% | 6.57% | 46.29% | Upgrade
|
| Cost of Revenue | 1,942 | 1,920 | 1,688 | 1,629 | 1,255 | Upgrade
|
| Gross Profit | 503.59 | 430.39 | 507.69 | 502.59 | 744.81 | Upgrade
|
| Selling, General & Admin | 251.24 | 244.51 | 227 | 216.31 | 150.57 | Upgrade
|
| Research & Development | 128.22 | 140.67 | 134.56 | 132.61 | 124.58 | Upgrade
|
| Other Operating Expenses | -12.93 | -15.69 | 5.17 | 14.39 | 15.44 | Upgrade
|
| Operating Expenses | 366.54 | 367.62 | 356.13 | 363.45 | 303.69 | Upgrade
|
| Operating Income | 137.06 | 62.77 | 151.57 | 139.14 | 441.12 | Upgrade
|
| Interest Expense | - | -96.16 | -102.6 | -92.6 | -73.82 | Upgrade
|
| Interest & Investment Income | - | 8.41 | 7.55 | 20.63 | 12.93 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -10.57 | 4.61 | -26.98 | -1.39 | Upgrade
|
| Other Non Operating Income (Expenses) | -83.21 | -7.46 | -7.76 | -11.09 | 1.36 | Upgrade
|
| EBT Excluding Unusual Items | 53.85 | -43.02 | 53.36 | 29.1 | 380.2 | Upgrade
|
| Impairment of Goodwill | - | - | - | -114.75 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -9.12 | -9.61 | -14.1 | 0.88 | 0.16 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.45 | -4.01 | 3.03 | -3.39 | -4.02 | Upgrade
|
| Asset Writedown | -38.19 | -9.71 | -3.84 | - | - | Upgrade
|
| Other Unusual Items | - | 8.94 | 6.89 | 22.75 | 19.06 | Upgrade
|
| Pretax Income | 7 | -57.17 | 45.35 | -65.4 | 395.39 | Upgrade
|
| Income Tax Expense | -3.28 | -8.07 | 0.8 | 6.53 | 65.62 | Upgrade
|
| Earnings From Continuing Operations | 10.27 | -49.1 | 44.55 | -71.93 | 329.77 | Upgrade
|
| Minority Interest in Earnings | -0.05 | 0 | -0.32 | -3.92 | -6.01 | Upgrade
|
| Net Income | 10.23 | -49.1 | 44.23 | -75.85 | 323.75 | Upgrade
|
| Net Income to Common | 10.23 | -49.1 | 44.23 | -75.85 | 323.75 | Upgrade
|
| Net Income Growth | - | - | - | - | 35.62% | Upgrade
|
| Shares Outstanding (Basic) | 511 | 409 | 340 | 345 | 344 | Upgrade
|
| Shares Outstanding (Diluted) | 511 | 409 | 340 | 345 | 344 | Upgrade
|
| Shares Change (YoY) | 24.99% | 20.25% | -1.31% | 0.10% | 3.05% | Upgrade
|
| EPS (Basic) | 0.02 | -0.12 | 0.13 | -0.22 | 0.94 | Upgrade
|
| EPS (Diluted) | 0.02 | -0.12 | 0.13 | -0.22 | 0.94 | Upgrade
|
| EPS Growth | - | - | - | - | 31.60% | Upgrade
|
| Free Cash Flow | -265.53 | -287.12 | -221.67 | -550.56 | 204.96 | Upgrade
|
| Free Cash Flow Per Share | -0.52 | -0.70 | -0.65 | -1.60 | 0.59 | Upgrade
|
| Dividend Per Share | - | 0.150 | - | 0.500 | 0.357 | Upgrade
|
| Dividend Growth | - | - | - | 40.02% | - | Upgrade
|
| Gross Margin | 20.59% | 18.31% | 23.12% | 23.58% | 37.24% | Upgrade
|
| Operating Margin | 5.60% | 2.67% | 6.90% | 6.53% | 22.06% | Upgrade
|
| Profit Margin | 0.42% | -2.09% | 2.01% | -3.56% | 16.19% | Upgrade
|
| Free Cash Flow Margin | -10.86% | -12.22% | -10.09% | -25.83% | 10.25% | Upgrade
|
| EBITDA | 377.18 | 281.65 | 331.12 | 297.97 | 594.55 | Upgrade
|
| EBITDA Margin | 15.42% | 11.98% | 15.08% | 13.98% | 29.73% | Upgrade
|
| D&A For EBITDA | 240.12 | 218.89 | 179.55 | 158.83 | 153.43 | Upgrade
|
| EBIT | 137.06 | 62.77 | 151.57 | 139.14 | 441.12 | Upgrade
|
| EBIT Margin | 5.60% | 2.67% | 6.90% | 6.53% | 22.06% | Upgrade
|
| Effective Tax Rate | - | - | 1.76% | - | 16.60% | Upgrade
|
| Revenue as Reported | - | 2,350 | 2,196 | 2,131 | 2,000 | Upgrade
|
| Advertising Expenses | - | 111.83 | 85.39 | 60.3 | 8.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.